Historical record - last NADAC effective date: 4/17/2024

Product Information

TOPIRAMATE 200 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0880 per EA under NDC 62756071213. Its NADAC has been published 547 times since Nov 28, 2013.

FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 200 MG TABLET

Topiramate
$0.0880per EA

Strength

200 mg/1

NDC

62756071213

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

4/17/2024

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090278

FDA Approved

3/27/2009

TE Code

AB

On Market Since

3/27/2009

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 200 MG TABLET has been published 547 times since Nov 28, 2013, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0880 per EA
All-time high$0.1389 (Jul 15, 2015)
All-time low$0.0880 (Apr 17, 2024)
Median price$0.1174
Average price$0.1158
Largest weekly change-19.3% (Apr 17, 2024)
Weeks tracked547
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-19.1%

5Y

-24.8%

All

-27.3%

Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0880 per EA (NDC 62756071213), effective May 15, 2024.

How has the price of TOPIRAMATE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 27.3%. It has been tracked across 547 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?

Since Nov 28, 2013, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1389 (Jul 15, 2015), with a median of $0.1174 per EA.

Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE 200 MG TABLET?

TOPIRAMATE 200 MG TABLET (NDC 62756071213) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.